Trial description:
A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events (MACEs) in Patients with Prostate Cancer and Cardiovascular Disease Receiving Degarelix (GnRH Receptor Antagonist) or Leuprolide (GnRH Receptor Agonist)
Contact name:
Dr Danish Mazhar
Trial start date:
Wednesday, September 11, 2019
Trial end date:
Tuesday, June 30, 2020
Trial tumour type:
Prostate
Show on Radiotherapy:
No
